GNAI3 encodes a heterotrimeric G protein alpha subunit that functions as a critical transducer of G protein-coupled receptor (GPCR) signaling. As a GTPase, GNAI3 cycles between active GTP-bound and inactive GDP-bound states to modulate downstream effectors 1. The protein inhibits adenylate cyclase activity and stimulates potassium channel activity, regulating intracellular cAMP levels and cellular excitability 2. GNAI3 also activates calcium-permeable TRPC5 ion channels in their active GTP-bound state. GNAI3 plays important roles in cellular homeostasis through multiple pathways. It regulates spermatogonial stem cell proliferation and apoptosis via interaction with RGS14 and the PLPP2-MAPK signaling axis 3. In immune contexts, GNAI3 suppresses colitis-associated tumorigenesis by blocking IL-6 signaling and reducing myeloid-derived suppressor cell expansion 4. GNAI3 also inhibits hepatocellular carcinoma cell migration and invasion, with expression downregulated by miR-222 in tumors 5. Additionally, GNAI3 maintains cochlear hair cell stereocilia and hearing function, with its expression regulated by the RNA-binding protein HuR 6. Clinically, loss-of-function GNAI3 mutations cause auriculocondylar syndrome, a craniofacial malformation characterized by micrognathia and mandibular hypoplasia resulting from disrupted endothelin-1-DLX5/6 signaling 17. These findings establish GNAI3 as a multifunctional signaling molecule with therapeutic potential in cancer, male infertility, and sensory disorders.